I. Irminger-Finger

发表

Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.

D. Birnbaum, S. Ryser, Eva Dizin, 2009, Cancer research.

BARD1 (BRCA1 associated RING domain 1)

I. Irminger-Finger, I. Irminger‐Finger, 2011 .

Preeclampsia: a danger growing in disguise.

I. Irminger-Finger, O. Irion, N. Jastrow, 2008, The international journal of biochemistry & cell biology.

The human cytotrophoblastic cell, a mononuclear chameleon.

I. Irminger-Finger, P. Bischof, I. Irminger‐Finger, 2005, The international journal of biochemistry & cell biology.

Basic Science of Breast Cancer in Older Patients

I. Irminger-Finger, I. Irminger‐Finger, 2010 .

A Role of BRCA1-Associated Protein BARD1 in Oxidative Stress Response and Signaling and Proliferation Control

I. Irminger-Finger, S. Pervais, 2008 .

Cellular and Molecular Crossroads of Cancer and Aging

I. Irminger-Finger, 2008 .

3rd Geneva aging workshop 2002: cancer, apoptosis and aging.

I. Irminger-Finger, 2003, Biochimica et biophysica acta.

BARD1 content correlates with increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.

I. Irminger-Finger, F. López‐Soriano, S. Busquets, 2006, Oncology reports.

Aging research in Switzerland

I. Irminger-Finger, C. Sieber, I. Irminger‐Finger, 2001, Experimental Gerontology.

Effect of microtubule-associated protein MHP1 on microtubule assembly and cell cycle progression in Saccharomyces cerevisiae.

I. Irminger-Finger, N. Mathis, Irmgard Irminger-Finger, 1998, Cell structure and function.

BARD1, a possible biomarker for breast and ovarian cancer.

I. Irminger-Finger, I. Irminger‐Finger, 2010, Gynecologic oncology.

BARD1 Expression During Spermatogenesis Is Associated with Apoptosis and Hormonally Regulated1

K. Krause, I. Irminger-Finger, A. Feki, 2004, Biology of reproduction.

Meeting report: Translational Research at the Aging and Cancer Interface.

H. Cohen, I. Irminger-Finger, C. Benz, 2007, Cancer Research.

The Drosophila melanogaster gene lethal(3)73Ah encodes a ring finger protein homologous to the oncoproteins MEL-18 and BMI-1.

I. Irminger-Finger, R. Nöthiger, I. Irminger‐Finger, 1995, Gene.

Pericentromeric instability and spontaneous emergence of human neoacrocentric and minute chromosomes in the alternative pathway of telomere lengthening.

S. Antonarakis, C. Jefford, S. Gagos, 2008, Cancer research.

Gene expression profiling of rat spermatogonia and Sertoli cells reveals signaling pathways from stem cells to niche and testicular cancer cells to surrounding stroma

S. Ryser, I. Irminger-Finger, Dominique A. Glauser, 2011, BMC Genomics.

Chemokine-induced cell death in CCR5-expressing neuroblastoma cells

K. Krause, I. Irminger-Finger, M. Dubois‐Dauphin, 2003, Journal of Neuroimmunology.

3 - Role of Tumor Suppressor BARD1 in Apoptosis and Cancer

C. Jefford, I. Irminger-Finger, Jian Wu, 2006 .

Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.

C. Jefford, K. Krause, I. Irminger-Finger, 2001, Molecular cell.

The Functions of Breast Cancer Susceptibility Gene 1 (BRCA1) Product and Its Associated Proteins

I. Irminger-Finger, B. Siegel, W. Leung, 1999, Biological chemistry.

Repression of the putative tumor suppressor gene Bard1 or expression of Notch4(int-3) oncogene subvert the morphogenetic properties of mammary epithelial cells.

I. Irminger-Finger, R. Montesano, A. Sappino, 2000, Advances in experimental medicine and biology.

Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.

Eva Dizin, I. Irminger-Finger, I. Irminger‐Finger, 2010, The international journal of biochemistry & cell biology.

Is there more to BARD1 than BRCA1?

C. Jefford, I. Irminger-Finger, Irmgard Irminger-Finger, 2006, Nature Reviews Cancer.

Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability

I. Irminger-Finger, G. Laurent, J. Limon, 2016, Oncotarget.

New concepts on BARD1: Regulator of BRCA pathways and beyond.

I. Irminger-Finger, M. Ratajska, M. Pilyugin, 2016, The international journal of biochemistry & cell biology.

Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.

I. Irminger-Finger, G. Laurent, P. Kozłowski, 2015, Oncology reports.

BARD1 mediates TGF-β signaling in pulmonary fibrosis

I. Irminger-Finger, R. Chambers, G. Laurent, 2015, Respiratory Research.

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example

I. Irminger-Finger, M. Stukan, P. Kozłowski, 2015, Scientific Reports.

Cancer predisposing BARD 1 mutations affect exon skipping and are associated with overexpression of specific BARD 1 isoforms

I. Irminger-Finger, G. Laurent, P. Kozłowski, 2015 .

Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.

I. Irminger-Finger, M. Pilyugin, I. Irminger‐Finger, 2014, The international journal of biochemistry & cell biology.

Oncogenic BARD1 isoforms expressed in gynecological cancers.

S. Ryser, Eva Dizin, C. Jefford, 2007, Cancer research.

Identification of BARD1 splice-isoforms involved in human trophoblast invasion.

I. Irminger-Finger, P. Bischof, B. Nikolić, 2007, The international journal of biochemistry & cell biology.

Nuclear–cytoplasmic translocation of BARD1 is linked to its apoptotic activity

C. Jefford, K. Krause, I. Irminger-Finger, 2004, Oncogene.

BRCA1-dependent and independent functions of BARD1.

I. Irminger-Finger, W. Leung, I. Irminger‐Finger, 2002, The international journal of biochemistry & cell biology.

BARD1 serum autoantibodies for the detection of lung cancer

S. Sardy, I. Irminger-Finger, G. Laurent, 2017, PloS one.

HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b

I. Irminger-Finger, L. Altucci, G. Garcia-Manero, 2013, PloS one.

Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

H. Hakonarson, K. Cole, Eva Dizin, 2012, Cancer research.

Therapeutics , Targets , and Chemical Biology Common Variation at BARD 1 Results in the Expression of an Oncogenic Isoform That In fl uences Neuroblastoma Susceptibility and Oncogenicity

H. Hakonarson, K. Cole, Eva Dizin, 2012 .

Chromosome instability in neoplasia: chaotic roots to continuous growth.

S. Gagos, I. Irminger-Finger, I. Irminger‐Finger, 2005, The international journal of biochemistry & cell biology.

BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer

I. Irminger-Finger, R. Zeillinger, N. Concin, 2021, Genes.

Mechanisms of chromosome instability in cancers.

C. Jefford, I. Irminger-Finger, I. Irminger‐Finger, 2006, Critical reviews in oncology/hematology.

Mutational spectrum of p53 mutations in primary breast and ovarian tumors.

I. Irminger-Finger, A. Feki, I. Irminger‐Finger, 2004, Critical reviews in oncology/hematology.

UCSD MOLECULE PAGES BARD1

I. Irminger-Finger, I. Irminger‐Finger, 2013 .

Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis

Karl-Heinz Krause, K. Krause, I. Irminger-Finger, 2006, International journal of cancer.

Science of cancer and aging.

I. Irminger-Finger, I. Irminger‐Finger, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Status of p53 in first-trimester cytotrophoblastic cells.

I. Irminger-Finger, M. Cohen, P. Bischof, 2007, Molecular human reproduction.

Cancer therapy: new drugs are emerging based on molecular targeting but still many challenges.

I. Irminger-Finger, L. Altucci, L. Balducci, 2007, The international journal of biochemistry & cell biology.

Identification of an apoptotic cleavage product of BARD1 as an autoantigen: a potential factor in the antitumoral response mediated by apoptotic bodies.

I. Irminger-Finger, J. Harb, F. Gautier, 2000, Cancer research.

BARD1: An independent predictor of survival in non‐small cell lung cancer

I. Irminger-Finger, A. Malkinson, M. Boulvain, 2012, International journal of cancer.

Non-coding RNAs: a novel level of genome complexity.

I. Irminger-Finger, G. Laurent, J. Kargul, 2014, The international journal of biochemistry & cell biology.

Unusually stable abnormal karyotype in a highly aggressive melanoma negative for telomerase activity

C. Jefford, S. Gagos, I. Irminger-Finger, 2008, Molecular Cytogenetics.

BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase

Karl-Heinz Krause, C. Jefford, K. Krause, 2005, Oncogene.

Telomere length, comorbidity, functional, nutritional and cognitive status as predictors of 5 years post hospital discharge survival in the oldest old

K. Krause, I. Irminger-Finger, F. Herrmann, 2011, The journal of nutrition, health & aging.

Telomere length and ApoE polymorphism in mild cognitive impairment, degenerative and vascular dementia

K. Krause, I. Irminger-Finger, F. Herrmann, 2010, Journal of the Neurological Sciences.

Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome

I. Irminger-Finger, L. Atzori, G. Casula, 2012, British Journal of Cancer.

Rare cancers: What we can learn from them.

I. Irminger-Finger, Geoff Laurent, J. Kargul, 2014, The international journal of biochemistry & cell biology.

In Vitro Repression of Brca1-associated RING Domain Gene, Bard1, Induces Phenotypic Changes in Mammary Epithelial Cells

I. Irminger-Finger, R. Montesano, A. Sappino, 1998, The Journal of cell biology.

Analysis of the primary sequence and microtubule-binding region of the Drosophila 205K MAP

I. Irminger-Finger, L. Goldstein, R. A. Laymon, 1990, The Journal of cell biology.

Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model.

K. Krause, I. Irminger-Finger, S. Pervaiz, 2009, Critical reviews in oncology/hematology.

In Vitro Repression of Brca 1-associated RING Domain Gene , Bard 1 , Induces Phenotypic Changes in Mammary Epithelial Cells

I. Irminger-Finger, R. Montesano, A. Sappino, 1998 .

MHP1, an essential gene in Saccharomyces cerevisiae required for microtubule function

I. Irminger-Finger, E. Hurt, S. Edelstein, 1996, The Journal of cell biology.

Identification and partial purification of calmodulin-binding microtubule-associated proteins from Neurospora crassa.

I. Irminger-Finger, D. van Tuinen, J. Arrighi, 1994, European journal of biochemistry.

BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatin.

I. Irminger-Finger, B. Henderson, Estefanía Martino-Echarri, 2016, Cancer letters.

The sex‐determining gene tra of Drosophila: molecular cloning and transformation studies.

I. Irminger-Finger, V. Pirrotta, R. Nöthiger, 1986, The EMBO journal.

RNA splicing: An ingenious gene self editing tool.

I. Irminger-Finger, G. Laurent, J. Kargul, 2017, International Journal of Biochemistry and Cell Biology.